Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Study of Dapansutrile Capsules in Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT03534297 Org: User:
Start: 05/16/18 End: 11/21/19 Due: 11/21/20

Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04540120 Org: User:
Start: 09/24/20 End: 07/28/22 Due: 07/28/23

Pilot Study of Dapansutrile Capsules in Schnitzler's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03595371 Org: User:
Start: 05/15/18 End: 05/29/18 Due: 05/29/19

Phase 1 Safety Study of Single and Multi-Dose Topically Applied OLT1177 Gel in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01636141 Org: User:
Start: 06/30/12 End: 08/31/12 Due: 08/31/13

Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain

Phase: N/A Priority: Normal
NCT ID: NCT02104050 Org: User:
Start: 04/30/14 End: 08/31/15 Due: 08/31/16

Phase 1 Safety and PK Study of OLT1177 Capsules

Phase: N/A Priority: Normal
NCT ID: NCT02134964 Org: User:
Start: 06/30/14 End: 12/31/14 Due: 12/31/15

Phase 2 Efficacy Trial of OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With OA of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT01768975 Org: User:
Start: 01/31/13 End: 08/31/13 Due: 08/31/14

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

Phase: N/A Priority: Normal
NCT ID: NCT05658575 Org: User:
Start: 01/06/23 End: 12/31/25 Due: 12/31/26